Thomas Serena

Thomas Serena

Auto-generated profile, based on publicly available information

Thomas Serena

Division of Vascular and Endovascular Surgery, West Virginia University, Morgantown, West Virginia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Journal of Comparative Effectiveness Research
Verified
Journal Article
Open access
OAOscar M Alvarez
Oscar M Alvarez
MGMark S Granick
Mark S Granick
ARAlexander Reyzelman
Alexander Reyzelman
TSThomas Serena
Thomas Serena
Aim: Compare foam dressings – Mepilex Border Flex (MxBF), Allevyn Life (AL) and Optifoam Gentle EX (OGEX) – in treatment of chronic wounds. Materials & methods: Prospective, randomized, controlled trial (crossover design). Subjects received one dressing for 2 weeks, then comparator dressing for following 2 weeks. Wound/periwound characteristics evaluated weekly at dressing change. Primary end point: dressing durability (incidence of exudate strikethrough). Results: Higher incidence of intact dressings (no strikethrough) at Day 7 (Week 1) with MxBF (6/17; 35.3%) compared with AL (1/18; 5.6%), and with MxBF (7/16; 43.8%) compared with OGEX (2/16; 12.5%; p < 0.05). No significant differences between groups regarding wound size reduction. Conclusion: MxBF had statistically greater durability than AL/OGEX during first critical week of treatment.

31 March 2022 in Cureus
Verified
Journal Article
Open access
PHPeter M. Habib
Peter M. Habib
TSThomas Serena
Thomas Serena
ADAmy Derosa
Amy Derosa
Since the advent of breast implants, there has been unprecedented controversy and FDA bands regarding their safety. There has been a demonstrated link with certain types of lymphoma, autoimmune disorders, and systemic illness associated with breast implants. A significant population of women currently pursue bilateral breast implant removal in hopes to alleviate a constellation of symptoms anecdotally known as “breast implant illness”. This is not yet an accepted clinical entity due to the lack of sound literature on the subject. Common presenting symptoms include fatigue, anxiety, chronic pain, endocrine, autonomic, and peripheral nervous system dysfunction. Currently, there is no standard of care or guideline for treating women experiencing such symptoms. The current literature regarding breast implant illness has been widely observational and descriptive. With over four million women across the globe with augmented breasts, the potential impact of this research is great. This paper presents three patients believed to be suffering from breast implant illness, who after en-bloc resection, experienced resolution of their symptoms.

31 March 2022 in Cureus
Verified
Journal Article
Open access
PHPeter M. Habib
Peter M. Habib
TSThomas Serena
Thomas Serena
CFCaitlin M. Flynn
Caitlin M. Flynn
AHAaron Hartkop
Aaron Hartkop
EWElizabeth Wey
Elizabeth Wey
ELEugene Laveroni
Eugene Laveroni
Fibrin-associated diffuse large B-cell lymphoma (FA-DLBCL) is in and of itself a rare entity and is a subset of the Epstein-Barr virus (EBV)-associated lymphoma. Due to its indolent course, FA-DLBCL is generally an incidental finding on histopathological examinations. We present the first reported case of FA-DLBCL found within a native aortic thrombus during an aorto-biiliac bypass. This is a 77-year-old male who was taken to the operative theater for open aorto-biiliac bypass secondary to aortooclusive disease resulting in intermittent claudication and gangrene of the right lower extremity digits. Intraoperatively, suspicious inflammatory changes were noted around the aorta. Pathological evaluation of the thrombus within the aorta noted cells of B-cell lineage with BCL2 and MYC positivity in addition to CD30 and EBV positivity. Postoperatively, the patient’s course was complicated by acute tubular necrosis, uremia, dialysis dependence, intubation, and cardiac arrhythmias including cardiac arrest. He was able to recover from these complications, however, he ultimately chose to self-enroll in hospice care. An extensive literature review of over 128 mentions of FA-DLBCL noted a complete paucity of reported cases of FA-DLBCL within a native aorta. The patient’s clinical presentation and histopathology without mass-forming lesions lead to the diagnosis of FA-DLBCL. FA-DLBCL is an extremely rare EBV+ lymphoproliferative disorder associated with chronic inflammation (DLBCL-CI). FA-DLBCL is a rare condition without defined uniform treatment. This article serves to highlight the first reported case of FA-DLBCL found within an abdominal aortic thrombus in a native aorta. Given the paucity of literature on this condition, postoperative treatment and long-term outcomes should be the focus of this condition.

15 February 2026 in Journal of Surgical Education
Verified
Journal Article
Closed access
TSThomas Serena
Thomas Serena
MWM. Libby Weaver
M. Libby Weaver
TSTing Sun
Ting Sun
KMKristyn Mannoia
Kristyn Mannoia
MSMichael C. Soult
Michael C. Soult
BSBrigitte K. Smith
Brigitte K. Smith

5 March 2022 in Journal of Vascular Surgery Cases, Innovations and Techniques
Verified
Journal Article
Open access
TSThomas Serena
Thomas Serena
WBWhitney Bailey
Whitney Bailey
SBScott Bendix
Scott Bendix
This report presents a 42-year-old African American woman with bilateral lower extremity pain, swelling, and paresthesias. Imaging demonstrated a large fibroid uterus with a mass effect in proximity to an iliocaval venous thrombosis. Mechanical thrombectomy was performed with recurrent infrarenal vena cava and bilateral iliac thrombosis, prompting hysterectomy. A subsequent intravascular ultrasound examination demonstrated relief of the external caval compression, but with left iliac vein compression by the right common iliac artery. The patient was managed successfully with mechanical thrombectomy and venous stenting. This case highlights the benefit of a multidisciplinary approach to complex iliocaval thrombosis from both an obstructive uterine myoma and May-Thurner syndrome.

1 January 2020 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
TSThomas Serena
Thomas Serena
RGRaisa Gao
Raisa Gao
KDKelly Dinnan
Kelly Dinnan
Mesenteric psuedocysts are rare tumors of the gastrointestinal mesentery that are seldom symptomatic. Although these benign tumors are most commonly found incidentally during work-up for other pathology, they can be troublesome in select patients based off size, location and risk of malignant transformation. This case is reported in accordance with SCARE Criteria [1]. A 24 year-old-male presents with life-long migratory abdominal pain presents with a one week history of acute pain associated with nausea. Computed tomography revealed free fluid in the pelvis and a thin-walled mesenteric cyst within the left, mid-abdominal mesentery measuring approximately 4.3 × 4.0 × 4.0 cm. The patient was admitted for resuscitation and planned delayed operative intervention. The patient underwent complete open enucleation secondary to location and in an attempt to limit injuries to or resection of small bowel. Pathological analysis revealed a mesenteric cyst with fluid culture positive for Propionibacterium acnes without true cystic wall consistent with an infected mesenteric pseudocyst. These lesions are difficult to diagnose secondary to varied presentation and lack of pathognomonic clinical, laboratory and imaging findings. Mesenteric pseudocyst have a low rate of recurrence after removal; however, surgical management is mandated due to risks of malignant transformation. This is a rare case of a mesenteric pseudocyst of small size presenting with lifelong abdominal pain secondary to its location near the root of the mesentery and inflammatory reaction secondary to infection. It is important to maintain a high index of suspicion for mesenteric cyst as many complications may result if misdiagnosed or without proper surgical management.